Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis

  • Nos C
  • Sastre-Garriga J
  • Borràs C
 et al. 
  • 9


    Mendeley users who have this article in their library.
  • 21


    Citations of this article.


Intravenous methylprednisolone (IVMP) has been shown to hasten recovery from attacks of multiple sclerosis (MS) without altering the long term evolution of the condition; however, there is little evidence available to suggest which patients are more likely to benefit from IVMP treatment.

Author-supplied keywords

  • 6-methylprednisolone
  • Clinically isolated syndrome
  • Expanded Disability Status Scale
  • Multiple sclerosis
  • Relapsing-remitting

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Carlos Nos

  • Jaume Sastre-Garriga

  • Cecília Borràs

  • Jordi Río

  • Mar Tintoré

  • Xavier Montalban

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free